Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 20/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9049529 | 1.00 | ALOX5 (0.61) | ALOX5 | |
| SCHEMBL9049698 | 0.79 | ALOX5 (0.51) | ALOX5 | |
| SCHEMBL9046703 | 0.79 | ALOX5 (0.51) | ALOX5 | |
| SCHEMBL9049086 | 0.76 | ALOX5 (1.00) | ALOX5 | |
| SCHEMBL9076539 | 0.75 | ALOX5 (0.78) | ALOX5 | |
| SCHEMBL9076535 | 0.75 | ALOX5 (0.78) | ALOX5 | |
| SCHEMBL9075754 | 0.75 | ALOX5 (0.78) | ALOX5 | |
| SCHEMBL9076531 | 0.75 | ALOX5 (0.78) | ALOX5 | |
| SCHEMBL9075748 | 0.75 | ALOX5 (0.78) | ALOX5 | |
| SCHEMBL9223598 | 0.73 | ALOX5 (1.00) | ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0555068-B1 | Oxime derivatives as 5-lipoxygenase inhibitors | ZENECA LTD (GB) | 1996-04-10 | — | — | EP | disclosed |
| US-5482966-A | LIPOXYGENASE ENZYME INHIBITORS AS ANTIINFLAMMATORY AGENTS | ZENECA LIMITED (GB) | 1996-01-09 | — | — | US | disclosed |
| EP-0610032-A1 | Acetanilide derivatives | ZENECA LIMITED (GB) | 1994-08-10 | — | — | EP | disclosed |
| US-5332757-A | Enzyme inhibitors | ZENECA LIMITED (GB) | 1994-07-26 | — | — | US | disclosed |
| EP-0555068-A1 | Oxime derivatives as 5-lipoxygenase inhibitors | ZENECA LIMITED (GB) | 1993-08-11 | — | — | EP | disclosed |